Loading organizations...
Loading organizations...
Biotechnology company developing a vaccine for Streptococcus pneumoniae.
GPN Vaccines has raised $18.4M across 2 funding rounds.
GPN Vaccines has raised $18.4M in total across 2 funding rounds.
GPN Vaccines has raised $18.4M in total across 2 funding rounds.
GPN Vaccines's investors include Forepont Capital Partners, Kern Capital.
GPN Vaccines has raised $18.4M across 2 funding rounds. Most recently, it raised $12.0M Other Equity in June 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 5, 2024 | $12.0M Other Equity | Forepont Capital Partners, Kern Capital | |
| Jan 30, 2023 | $6.4M Series A | Forepont Capital Partners |